This suggests the existence of a regulatory axis, involving TRIM32, USP11 and SDC2, which plays a pivotal role in determining the stability of ARID1A and, consequently, its impact as an oncogene or tumour suppressor.36 Here, ARID1A is linked to neoplasm.